You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced solid malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Malignancies Trial in Irving (GIM122)

Not yet recruiting
  • Advanced Solid Malignancies
  • Irving, Texas
    NEXT Dallas
Sep 8, 2023

Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD2014)

Active, not recruiting
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
  • +1 more
Feb 2, 2023

Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)

Not yet recruiting
  • Advanced Solid Tumors Cancer
  • +3 more
  • New York, New York
    Memorial Slone Kettering Cancer Center
Jun 26, 2023

Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • (no location specified)
Jul 12, 2023

Advanced Solid Malignancies Trial in Tbilisi, Chisinau, Cluj-Napoca (AZD5305, Itraconazole)

Recruiting
  • Advanced Solid Malignancies
  • Tbilisi, Georgia
  • +2 more
Jan 20, 2023

Solid Tumor Trial in Tokyo (GEN1046)

Recruiting
  • Solid Tumor
  • GEN1046
  • Tokyo, Japan
  • +1 more
Jan 13, 2023

Advanced Solid Malignancies Trial in Chuo-ku (Ceralasertib)

Recruiting
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
    Research Site
Jul 20, 2022

PTEN-null Advanced Solid Tumors Trial in New York (Leflunomide)

Not yet recruiting
  • PTEN-null Advanced Solid Tumors
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 8, 2022

Tumor, Cancer Trial in Netherlands, United Kingdom, United States (AZD6244)

Active, not recruiting
  • Tumor
  • Cancer
  • Aurora, Colorado
  • +3 more
Dec 22, 2022

Solid Malignancies or Lymphomas Trial in Wollongong (IBI363)

Recruiting
  • Solid Malignancies or Lymphomas
  • IBI363
  • Wollongong, New South Wales, Australia
    Southern Medical Day Care Centre
Sep 4, 2022

Advanced Solid Malignancies Trial in Kogarah, Macquarie, Frankston (YH002)

Completed
  • Advanced Solid Malignancies
  • Kogarah, New South Wales, Australia
  • +2 more
Jul 21, 2022

Advanced Solid Tumor Trial in Canton, Austin, San Antonio (Tipifarnib)

Recruiting
  • Advanced Solid Tumor
  • Canton, Ohio
  • +2 more
Aug 19, 2022

Solid Tumor, Tumors Trial in Lund, Solna, Uppsala (ATOR-1017)

Active, not recruiting
  • Solid Tumor
  • Neoplasms
  • ATOR-1017
  • Lund, Sweden
  • +2 more
Aug 16, 2022

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

Recruiting
  • Cancer
  • +4 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 24, 2023

Advanced Solid Tumor Trial in Jinan, Shanghai (ILB2109)

Not yet recruiting
  • Advanced Solid Tumor
  • Jinan, Shandong, China
  • +1 more
Mar 12, 2022

Advanced/Metastatic Solid Tumor Trial in United States (KZR-261)

Recruiting
  • Advanced/Metastatic Solid Tumor
  • Los Angeles, California
  • +6 more
Aug 10, 2022

Solid Tumor, Lymphoma Trial in Los Angeles (DZ-002)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 2, 2022

Advanced Solid Malignancies Trial in Worldwide (Ami-LC-MD, Ami-LC, Ami-HC)

Recruiting
  • Advanced Solid Malignancies
  • West Hollywood, California
  • +13 more
Jan 31, 2023

Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-OX40 Antibody BMS 986178
  • TLR9 Agonist SD-101
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 13, 2022

Advanced Solid Malignancies Trial in Taipei (OB318 capsule)

Recruiting
  • Advanced Solid Malignancies
  • OB318 capsule
  • Taipei, Taiwan
  • +1 more
Nov 12, 2021

Advanced Cancers, Melanoma Trial in Houston (MGN1703, Ipilimumab)

Active, not recruiting
  • Advanced Cancers
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 11, 2022

Solid Tumor, Non-Hodgkin Lymphoma Trial in Shanghai, Hangzhou (Gentulizumab)

Recruiting
  • Solid Tumor
  • Non-Hodgkin Lymphoma
  • Shanghai, Shanghai, China
  • +1 more
Jan 21, 2022

Solid Tumor Trial in Shanghai (ICP-105)

Completed
  • Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Jul 5, 2022

Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

Terminated
  • Solid Tumors
  • NHL
  • Los Angeles, California
  • +7 more
Jan 18, 2023

B-cell Non Hodgkin Lymphoma, Advanced Solid Tumor Trial in Edmonton, Toronto, Montréal (PCLX-001 treated)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • Advanced Solid Tumor
  • PCLX-001 treated
  • Edmonton, Alberta, Canada
  • +2 more
Feb 28, 2022